newest glp-1 medications for type 2 diabetes 2025 New Guidelines in GLP-1 Medications: What's New in
Description
You can adjust your injection schedule to fit lifestyle changes, though maintaining a consistent day and time each week optimizes the medication's steady-state effect
Retrieved 10 April 2022
Ozempic (semaglutide) is a GLP-1 receptor agonist licensed in the UK for type 2 diabetes treatment, with common gastrointestinal side effects including nausea and diarrhoea
Air bubbles trapped in cartridges reduce actual drug delivery and create the false sensation of a successful injection
For some users, they come with side effects such as nausea, diarrhea or constipation
